Morrow W J, Isenberg D A, Parry H F, Shen L, Okolie E E, Farzaneh F, Shall S, Snaith M L
Ann Rheum Dis. 1982 Aug;41(4):396-402. doi: 10.1136/ard.41.4.396.
Sera from 41 patients with systemic lupus erythematosus (SLE), 87 controls with various diseases, and 30 normal subjects were examined for poly (adenosine diphosphate-ribose) and ds DNA binding. Elevated levels of poly (ADP-ribose) binding were found in 73% of the SLE patients compared with 58% who had raised ds DNA binding. In a further study of 160 sera from 27 patients with SLE, levels of antipoly (ADP-ribose) antibodies were shown to correlate with clinical activity better than either anti-ds DNA or ss DNA antibodies.
对41例系统性红斑狼疮(SLE)患者、87例患有各种疾病的对照者以及30名正常受试者的血清进行了多聚(二磷酸腺苷核糖)和双链DNA结合检测。与双链DNA结合升高的58%的SLE患者相比,73%的SLE患者多聚(ADP - 核糖)结合水平升高。在对27例SLE患者的160份血清进行的进一步研究中,抗多聚(ADP - 核糖)抗体水平与临床活动的相关性优于抗双链DNA或抗单链DNA抗体。